لابراتوارهای سینادارو
دسینا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/21 Fiscal Year 2026/03/2012 Month | 2025/07/07 Fiscal Year 2025/03/2012 Month | 2024/07/13 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 3.977 Trillion | 2.072 Trillion | 745.2 Billion | |
Short-Term Investments | 3.028 Trillion | - | - | |
Trade Receivables | 15.038 Trillion | 9.863 Trillion | 5.014 Trillion | |
Prepayments | 5.563 Trillion | 2.104 Trillion | 2.615 Trillion | |
Raw Materials & Packaging Inventory | 5.351 Trillion | 3.339 Trillion | 2.853 Trillion | |
Work-in-Progress Inventory | 1.336 Trillion | 990.525 Billion | 773.171 Billion | |
Finished Goods Inventory | 742.915 Billion | 995.926 Billion | 239.109 Billion | |
Spare Parts Inventory | 369.156 Billion | 267.15 Billion | 211.785 Billion | |
Goods in Transit | 311.357 Billion | 276.909 Billion | 145.902 Billion | |
Our Goods on Consignment with Others | 278.878 Billion | 223.443 Billion | 264.751 Billion | |
Other Inventories | 143.681 Billion | 38.059 Billion | 54.188 Billion | |
Inventories | 8.533 Trillion | 6.131 Trillion | 4.541 Trillion | |
Total Current Assets | 36.139 Trillion | 20.171 Trillion | 12.916 Trillion | |
Long-Term Investments | 10.592 Billion | 12.383 Billion | 12.236 Billion | |
Intangible Assets | 22.554 Billion | 27.293 Billion | 26.493 Billion | |
Property, Plant & Equipment | 4.854 Trillion | 4.332 Trillion | 4.905 Trillion | |
Net Fixed Assets | 4.854 Trillion | 4.332 Trillion | 4.905 Trillion | |
Total Non-Current Assets | 4.887 Trillion | 4.372 Trillion | 4.944 Trillion | |
Total Assets | 41.026 Trillion | 24.542 Trillion | 17.859 Trillion | |
Trade Payables | 1.281 Trillion | 1.425 Trillion | 1.045 Trillion | |
Income Tax Provision | 3.49 Trillion | 1.94 Trillion | 1.54 Trillion | |
Other Provisions | 132.958 Billion | 154.295 Billion | 91.236 Billion | |
Proposed & Payable Dividends | 98.606 Billion | 2.088 Trillion | 1.895 Trillion | |
Current Borrowings | 5.017 Trillion | 2.112 Trillion | 2.574 Trillion | |
Total Current Liabilities | 10.02 Trillion | 7.719 Trillion | 7.145 Trillion | |
Employee Termination Benefits Provision | 1.88 Trillion | 1.095 Trillion | 688.339 Billion | |
Total Non-Current Liabilities | 1.88 Trillion | 1.095 Trillion | 688.339 Billion | |
Total Liabilities | 11.9 Trillion | 8.815 Trillion | 7.834 Trillion | |
Capital | 2.4 Trillion | 2.4 Trillion | 2.4 Trillion | |
Retained Earnings | 26.523 Trillion | 13.086 Trillion | 7.406 Trillion | |
Legal Reserve | 240 Billion | 240 Billion | 240 Billion | |
Share Premium Reserve | -37.288 Billion | 2.141 Billion | -19.998 Billion | |
Total Equity | 29.126 Trillion | 15.728 Trillion | 10.026 Trillion | |
Total Liabilities & Equity | 41.026 Trillion | 24.542 Trillion | 17.859 Trillion | |
Approved Capital | 2.4 Trillion | 2.4 Trillion | 2.4 Trillion | |
Approved Retained Earnings | 12.861 Trillion | 7.23 Trillion | 3.315 Trillion | |
Approved Legal Reserve | 240 Billion | 240 Billion | 240 Billion | |
Total Approved Equity (at AGM) | 15.501 Trillion | 9.87 Trillion | 5.955 Trillion |